Literature DB >> 6120195

Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages.

C J Liang-Takasaki, P H Mäkelä, L Leive.   

Abstract

Salmonella transductants and recombinants differing the O-antigenic side chain of their lipopolysaccharide are taken up at different rates by the murine macrophage-like cell line J774. Bacteria containing abequose, mannose, rhamnose, and galactose in O-antigenic side chain were taken up at the slowest rate; the one containing tyvelose instead of abequose was taken up at an intermediate rate; and the one containing mannose, N-acetylglucosamine, and glucose, instead of the above sequence, was taken up at the highest rate. These rates correlate well with the known virulence of these strains; the most virulent is the one taken up slowest, the one taken up at an intermediate rate is less virulent, and the one taken up fastest is the least virulent. The differences in ingestion rates reflect differences in affinity of the bacteria for the macrophages and not in the rate of ingestion once interaction has occurred, suggesting a receptor-mediated process. The majority of uptake is probably dependent on complement, as shown by the requirement for a serum component(s) destroyed by heating at 56 degrees C or by incubation with zymosan. Specific antibody is not required. We therefore postulate that relative virulence in vivo may reflect the relative ability of the polysaccharide of bacterial lipopolysaccharide to activate complement, thus determining the susceptibility of the bacteria to ingestion via the complement receptor of phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6120195

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Pore formation by complement in the outer membrane of gram-negative bacteria studied with asymmetric planar lipopolysaccharide/phospholipid bilayers.

Authors:  G Schröder; K Brandenburg; L Brade; U Seydel
Journal:  J Membr Biol       Date:  1990-11       Impact factor: 1.843

2.  The polysaccharide portion of lipopolysaccharide regulates antigen-specific T-cell activation via effects on macrophage-mediated antigen processing.

Authors:  N M Zirk; S F Hashmi; H K Ziegler
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Genomic basis of endosymbiont-conferred protection against an insect parasitoid.

Authors:  Allison K Hansen; Christoph Vorburger; Nancy A Moran
Journal:  Genome Res       Date:  2011-09-23       Impact factor: 9.043

4.  Bacterial cell wall composition, lysozyme resistance, and the induction of chronic arthritis in rats.

Authors:  T J Lehman; J B Allen; P H Plotz; R L Wilder
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

5.  Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity.

Authors:  D L Dunn; R A Barke; N B Knight; E W Humphrey; R L Simmons
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

6.  Bactericidal and opsonizing effects of normal serum on mutant strains of Salmonella typhimurium.

Authors:  M F Shaio; H Rowland
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  Brucella abortus rough mutants are cytopathic for macrophages in culture.

Authors:  Jianwu Pei; Thomas A Ficht
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Conservation and diversity of Campylobacter pyloridis major antigens.

Authors:  G I Perez-Perez; M J Blaser
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

9.  The role of O-antigen polysaccharide in the activation of neutrophils by lipopolysaccharides of Salmonella species.

Authors:  O Rasool; N A Nnalue; C Jarstrand
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

Review 10.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.